Sara Lee Corp. (SLE)

Symbols:
Authors:

All Comments on SLE

  • commenter
    Long-Short
    Guy
    Jan 16 12:10 PM
    Under The Radar News - Wednesday [view article]
    It's so amazing to see banks in Japan and China looking to bail out the leading US investment banks. How the mighty have fallen. Reply
  • commenter
    SA Editor
    Eli Hoffmann
    Jan 16 10:55 AM
    Under The Radar News - Wednesday [view article]
    Thanks for the heads-up. I amended the article based on your corrections. Reply
  • commenter
    reagan
    Jan 16 10:41 AM
    Under The Radar News - Wednesday [view article]
    You are wrong about the iphone numbers.Apple says it would sell 10m by the end of 08'.Right now,they are ahead of schedule,looking to sell over 12m phones. Reply
  • commenter
    User 140676
    Jan 16 10:33 AM
    Under The Radar News - Wednesday [view article]
    The iPhone target was 10 Million sold by the end of 2008. Reply
  • commenter
    richandmer
    Oct 23 08:23 PM
    My Website
    3 Sales and 4 New Buys: Redwood Trust, Gehl Corp., Shoe Carnival, Charlotte Russe [view article]
    The stocks you sold have not done well and the stocks you are buying are even worse. Why not at least wait until they turn around a bit? Reply
  • commenter
    arkla
    Oct 23 06:40 AM
    3 Sales and 4 New Buys: Redwood Trust, Gehl Corp., Shoe Carnival, Charlotte Russe [view article]
    (GEHL) got out of the farm machinery business this year. Reply
  • commenter
    DannyHaszard
    Mar 16 10:03 AM
    My Website
    Capture The CalPERS Effect For Stock Ideas [view article]
    Lilly shares, which traded this afternoon 3-15-07 at about $52, have fallen about 6 percent in the past year.

    Zyprexa is Eli Lilly's lifeblood performer.-Daniel Haszard     Reply
  • commenter
    Asif
    Jun 25 09:13 PM
    My Website
    One Page Barron's Summary [view article]
    Probably the following statement by the CEO Antonio Perez during the Kodak conference call when asked whether Kodak was on track for back to school <i>"I never said we’re going to be back to school. We’re still on track with our project. We are — I have no news really to report, and you know why I don’t want to report news until the closest possible time, the latest possible time. So but we keep investing in that business. We are accelerating things and I feel that we are in good shape, but there is nothing else to report."</i>...

    It is interesting to see the generic drug maker Teva (TEVA) back where it was a year ago. The run-up that started last year was in anticipation on looming patent expirations at big pharma companies like Pfizer (PFE) and Merck. I feel that the Zocor pricing move by Merck is likely to be negative for the generic drug companies like Teva, Ranbaxy, Mylan and Dr. Reddy's but would barely affect Pfizer. Pfizer raised its dividend about six months ago and I doubt they would do it again anytime soon.     Reply

Trading Center